US Stock MarketDetailed Quotes

Citius Oncology (CTOR)

Watchlist
  • 1.080
  • -0.020-1.82%
Close Jan 15 16:00 ET
91.58MMarket Cap-3.18P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Citius Oncology (CTOR) Income Statement

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Sep 30, 2025
(Q4)Sep 30, 2025
(Q3)Jun 30, 2025
(Q2)Mar 31, 2025
(Q1)Dec 31, 2024
(FY)Sep 30, 2024
(Q4)Sep 30, 2024
(Q3)Jun 30, 2024
(Q2)Mar 31, 2024
(Q1)Dec 31, 2023
Total revenue
0
0
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
14.34%23.52M
-29.35%4.71M
6.83%4.94M
59.25%7.47M
39.52%6.39M
69.72%20.57M
6.67M
4.63M
4.69M
4.58M
Selling and administrative expenses
9.31%17.1M
-32.34%3.64M
14.56%4.01M
29.60%4.33M
49.36%5.13M
98.56%15.65M
--5.37M
--3.5M
--3.34M
--3.43M
-General and administrative expense
9.31%17.1M
-32.34%3.64M
14.56%4.01M
29.60%4.33M
49.36%5.13M
98.56%15.65M
--5.37M
--3.5M
--3.34M
--3.43M
Research and development costs
30.32%6.42M
-16.97%1.08M
-17.07%938.28K
132.73%3.14M
10.10%1.26M
16.14%4.93M
--1.3M
--1.13M
--1.35M
--1.15M
Operating profit
-14.34%-23.52M
29.35%-4.71M
-6.83%-4.94M
-59.25%-7.47M
-39.52%-6.39M
-69.72%-20.57M
-6.67M
-4.63M
-4.69M
-4.58M
Net non-operating interest income expense
-181.66K
-20.9K
-160.76K
0
Non-operating interest income
--36.37K
----
----
----
----
--0
----
----
----
----
Non-operating interest expense
--218.03K
--57.28K
--160.76K
----
----
--0
----
----
----
----
Other net income (expense)
Income before tax
-15.22%-23.7M
29.04%-4.73M
-10.30%-5.11M
-59.25%-7.47M
-39.52%-6.39M
-69.72%-20.57M
-6.67M
-4.63M
-4.69M
-4.58M
Income tax
83.50%1.06M
83.50%264.24K
83.50%264.24K
83.50%264.24K
83.50%264.24K
0.00%576K
144K
144K
144K
144K
Net income
-17.08%-24.76M
26.66%-5M
-12.51%-5.37M
-59.97%-7.74M
-40.86%-6.66M
-66.56%-21.15M
-6.81M
-4.77M
-4.84M
-4.73M
Net income continuous Operations
-17.08%-24.76M
26.66%-5M
-12.51%-5.37M
-59.97%-7.74M
-40.86%-6.66M
-66.56%-21.15M
---6.81M
---4.77M
---4.84M
---4.73M
Minority interest income
Net income attributable to the parent company
-17.08%-24.76M
26.66%-5M
-12.51%-5.37M
-59.97%-7.74M
-40.86%-6.66M
-66.56%-21.15M
-6.81M
-4.77M
-4.84M
-4.73M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-17.08%-24.76M
26.66%-5M
-12.51%-5.37M
-59.97%-7.74M
-40.86%-6.66M
-66.56%-21.15M
-6.81M
-4.77M
-4.84M
-4.73M
Basic earnings per share
-9.68%-0.34
36.99%-0.06
-19.41%-0.08
-62.06%-0.11
-35.63%-0.09
-73.93%-0.31
-0.0952
-0.067
-0.0679
-0.0664
Diluted earnings per share
-9.68%-0.34
36.99%-0.06
-19.41%-0.08
-62.06%-0.11
-35.63%-0.09
-73.93%-0.31
-0.0952
-0.067
-0.0679
-0.0664
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Audit Opinions
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
(FY)Sep 30, 2025(Q4)Sep 30, 2025(Q3)Jun 30, 2025(Q2)Mar 31, 2025(Q1)Dec 31, 2024(FY)Sep 30, 2024(Q4)Sep 30, 2024(Q3)Jun 30, 2024(Q2)Mar 31, 2024(Q1)Dec 31, 2023
Total revenue 0000000000
Operating revenue --0--0--0--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense 14.34%23.52M-29.35%4.71M6.83%4.94M59.25%7.47M39.52%6.39M69.72%20.57M6.67M4.63M4.69M4.58M
Selling and administrative expenses 9.31%17.1M-32.34%3.64M14.56%4.01M29.60%4.33M49.36%5.13M98.56%15.65M--5.37M--3.5M--3.34M--3.43M
-General and administrative expense 9.31%17.1M-32.34%3.64M14.56%4.01M29.60%4.33M49.36%5.13M98.56%15.65M--5.37M--3.5M--3.34M--3.43M
Research and development costs 30.32%6.42M-16.97%1.08M-17.07%938.28K132.73%3.14M10.10%1.26M16.14%4.93M--1.3M--1.13M--1.35M--1.15M
Operating profit -14.34%-23.52M29.35%-4.71M-6.83%-4.94M-59.25%-7.47M-39.52%-6.39M-69.72%-20.57M-6.67M-4.63M-4.69M-4.58M
Net non-operating interest income expense -181.66K-20.9K-160.76K0
Non-operating interest income --36.37K------------------0----------------
Non-operating interest expense --218.03K--57.28K--160.76K----------0----------------
Other net income (expense)
Income before tax -15.22%-23.7M29.04%-4.73M-10.30%-5.11M-59.25%-7.47M-39.52%-6.39M-69.72%-20.57M-6.67M-4.63M-4.69M-4.58M
Income tax 83.50%1.06M83.50%264.24K83.50%264.24K83.50%264.24K83.50%264.24K0.00%576K144K144K144K144K
Net income -17.08%-24.76M26.66%-5M-12.51%-5.37M-59.97%-7.74M-40.86%-6.66M-66.56%-21.15M-6.81M-4.77M-4.84M-4.73M
Net income continuous Operations -17.08%-24.76M26.66%-5M-12.51%-5.37M-59.97%-7.74M-40.86%-6.66M-66.56%-21.15M---6.81M---4.77M---4.84M---4.73M
Minority interest income
Net income attributable to the parent company -17.08%-24.76M26.66%-5M-12.51%-5.37M-59.97%-7.74M-40.86%-6.66M-66.56%-21.15M-6.81M-4.77M-4.84M-4.73M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -17.08%-24.76M26.66%-5M-12.51%-5.37M-59.97%-7.74M-40.86%-6.66M-66.56%-21.15M-6.81M-4.77M-4.84M-4.73M
Basic earnings per share -9.68%-0.3436.99%-0.06-19.41%-0.08-62.06%-0.11-35.63%-0.09-73.93%-0.31-0.0952-0.067-0.0679-0.0664
Diluted earnings per share -9.68%-0.3436.99%-0.06-19.41%-0.08-62.06%-0.11-35.63%-0.09-73.93%-0.31-0.0952-0.067-0.0679-0.0664
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Audit Opinions Unqualified Opinion with Explanatory Notes--------Unqualified Opinion with Explanatory Notes--------
Market Insights
Nancy Pelosi Portfolio
No. Symbol % Chg
Sample Name
Sample Code
 +6.63%
Sample Name
Sample Code
 +3.27%
Sample Name
Sample Code
 +2.15%
4
NVIDIA
NVDA
+2.13%
5
Broadcom
AVGO
+0.92%
China Concept Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +15.64%
Sample Name
Sample Code
 +12.57%
Sample Name
Sample Code
 +10.73%
4
Alibaba
BABA
+10.66%
5
Taiwan Semiconductor
TSM
+7.43%
View More
The Fed Delivers Third Consecutive Rate Cut as Expected! How to Position for Year-End U.S. Equity Ma
On December 19, the Bank of Japan raised interest rates by 25 basis points as expected, in line with market forecasts. On the evening of Dec Show More
December FOMC Interest Rate Meeting
[Opportunity Express] MRVL Continues to Bet on Optical Interconnects: Is Now a Good Time to Enter the Market?

- No more -